The COVID-19/Influenza A+B/RSV/Adenovirus Antigen Combo Rapid Test is a lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2, influenza A virus, influenza B virus, respiratory syncytial virus (RSV) and adenovirus antigens in nasopharyngeal swab specimens from individuals with signs and symptoms of respiratory infection.
| Catalog No. | Specifications | Reaction Time | Sensitivity | Specificity | Storage Condition | Shelf Life | Certification |
|---|---|---|---|---|---|---|---|
| IGMq525-B025 | 25 tests/box | 15 mins |
COVID-19:95.45% |
COVID-19:> 99.9% |
4-30℃ | 24 months | CE |
This product cannot be sold in the United States.